Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference7 articles.
1. Rad in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection;Kahan;Transplantation,2001
2. Efficacy of sirolimus compared with azathioprine on reduction of acute renal allograft rejection: a randomised multicentre study;Kahan;Lancet,2000
3. Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies;Vitko;Am J Transplant,2004
4. SDZ RAD, a new rapamycin derivative: pharmacologic properties in vitro and in vivo;Schuler;Transplantation,1996
5. Epidemiology of cardiovascular disease in chronic renal disease;Foley;J Am Soc Nephrol,1998
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of Kidney Transplant Function, Lipid Metabolism Disorders, and Glucose and Hemoglobin Concentration in Transplant Patients Treated With Proliferation Signal Inhibitor (Everolimus) or Calcineurin Inhibitor (Tacrolimus);Transplantation Proceedings;2020-10
2. Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial;Transplant International;2018-08-28
3. Atherosclerosis in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis;Kardiologia Polska;2018-01-23
4. Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy;Transplantation;2017-10
5. Changes in lipid and carbohydrate metabolism under mTOR- and calcineurin-based immunosuppressive regimen in adult patients after liver transplantation;European Journal of Internal Medicine;2016-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3